Endovascular Treatment of Pelvic Arteries and Inguinal Arteries

Chapter

Abstract

Iliofemoral arterial occlusive disease is a commonly encountered pattern of peripheral artery disease (PAD) in patients with claudication or critical limb ischemia (CLI). Technical advances and clinical trial results have improved the endovascular approach to iliac and superficial femoral artery (SFA) disease, with recent emerging data supporting common femoral artery (CFA) interventions as well. This chapter reviews the background, techniques, data, and advances for treating proximal arterial disease in symptomatic patients.

References

  1. 1.
    Palmaz JC, Laborde JC, Rivera FJ, Encarnacion CE, Lutz JD, Moss JG. Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol. 1992;15(5):291–7.CrossRefGoogle Scholar
  2. 2.
    Reekers JA, Vorwerk D, Rousseau H, et al. Results of a European multicentre iliac stent trial with a flexible balloon expandable stent. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2002;24(6):511–5.CrossRefGoogle Scholar
  3. 3.
    Klein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006;238(2):734–44.CrossRefGoogle Scholar
  4. 4.
    Stockx L, Poncyljusz W, Krzanowski M, Schroe H, Allocco DJ, Dawkins KD. Express LD vascular stent in the treatment of iliac artery lesions: 24-month results from the MELODIE trial. J Endovasc Ther. 2010;17(5):633–41.CrossRefGoogle Scholar
  5. 5.
    Humphries MD, Armstrong E, Laird J, Paz J, Pevec W. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease. J Vasc Surg. 2014;60(2):337–43.CrossRefGoogle Scholar
  6. 6.
    Ponec D, Jaff MR, Swischuk J, et al. The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004;15(9):911–8.CrossRefGoogle Scholar
  7. 7.
    Krol KL, Saxon RR, Farhat N, et al. Clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease. J Vasc Interv Radiol (JVIR). 2008;19(1):15–22.CrossRefGoogle Scholar
  8. 8.
    Jaff MR, Katzen BT. Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease. J Vasc Interv Radiol (JVIR). 2010;21(10):1489–94.CrossRefGoogle Scholar
  9. 9.
    Martin EC, Katzen BT, Benenati JF, et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (JVIR). 1995;6(6):843–9.CrossRefGoogle Scholar
  10. 10.
    Reyes R, Carreira JM, Gude F, et al. Long-term follow-up of iliac wallstents. Cardiovasc Intervent Radiol. 2004;27(6):624–31.CrossRefGoogle Scholar
  11. 11.
    Mwipatayi BP, Thomas S, Wong J, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2011;54(6):1561–70.CrossRefGoogle Scholar
  12. 12.
    Bekken JA, Vos JA, Aarts RA, de Vries JP, Fioole B. DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial. Trials. 2012;13:215.CrossRefGoogle Scholar
  13. 13.
    Bosch JL, Hunink MGM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87–96.CrossRefGoogle Scholar
  14. 14.
    Ansel GM, Kazienko BT, Lipman JC, et al. Long-term and secondary patency of iliac arterial Wallstenting followed with ongoing limb surveillance. Am J Cardiol. 2001;88(Suppl. 5A):G29.Google Scholar
  15. 15.
    Murphy TP, Webb MS, Lambiase RE, et al. Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of Wallstents: 3-year experience. J Vasc Interv Radiol. 1996;7:21–7.CrossRefGoogle Scholar
  16. 16.
    Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999–1009.CrossRefGoogle Scholar
  17. 17.
    Bosiers M, Deloose K, Callaert J, et al. Bravissimo: 12-month results from a large scale prospective trial. J Cardiovasc Surg. 2013;54(2):235–53.Google Scholar
  18. 18.
    Willman JK, Baumert B, Schertler T, et al. Aortoiliac and lower extremity arteries assesses with 16 detectorrow CT angiography: prospective comparison with digital subtraction angiography. Radiology. 2005;236:1083–93.CrossRefGoogle Scholar
  19. 19.
    Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226:798–811.CrossRefGoogle Scholar
  20. 20.
    Timaran CH, Ohki T, Gargiulo NJ, et al. Iliac artery stenting in patients with poor distal runoff: influence of concomitant infrainguinal arterial reconstruction. J Vasc Surg. 2003;38(3):479–84.CrossRefGoogle Scholar
  21. 21.
    Arko F, Mettauer M, McCollough R, Patterson D, Manning L, Lee S, Buckley CJ. Use of intravascular ultrasound improves long-term clinical outcome in the endovascular management of atherosclerotic aortoiliac occlusive disease. J Vasc Surg. 1998;27:614–23.CrossRefGoogle Scholar
  22. 22.
    Maldonado TS, Westin GG, Jazaeri O, et al. Treatment of aortoiliac occlusive disease with the endologix AFX unibody endograft. Eur J Vasc Endovasc Surg. 2016;52(1):64–74. article in press.CrossRefGoogle Scholar
  23. 23.
    Goverde PC, Grimme FA, Verbruggen PJ, Reijnen MM. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg. 2013;54(3):383–7.Google Scholar
  24. 24.
    Murphy KD, Encarnacion CE, Le VA, et al. Iliac artery stent placement with the Palmaz stent: follow-up study. J Vasc Interv Radiol. 1995;6:321–9.CrossRefGoogle Scholar
  25. 25.
    Bosiers M, Deloose K, Callaert J, Verbist J, Keirse K, Peeters P. BRAVISSIMO study: 12-month results from the TASC A/B subgroup. J Cardiovasc Surg. 2012;53(1):91–9.Google Scholar
  26. 26.
    Ansel GM. Endoprosthesis in complex iliac stenosis and occlusion: results of the prospective, multicenter randomized trial. Curr Interv Cardiol Rep. 1999;1:303–9.PubMedGoogle Scholar
  27. 27.
    Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent graft. Radiology. 2000;217:95–104.CrossRefGoogle Scholar
  28. 28.
    Mwipatayi P. Covered balloon-expandable versus bare metal stents for complex iliac disease – final results of the COBEST-Study. Presented at: The Leipzig Interventional Course 2010. Leipzig, Germany, 27–30 January 2010.Google Scholar
  29. 29.
    Haulon S, Mounier-Vehier C, Gaxotte V, et al. Percutaneous reconstruction of the aortoiliac bifurcation with the ‘kissing stents’ technique: long-term follow-up in 106 patients. J Endovasc Ther. 2002;9:363–8.CrossRefGoogle Scholar
  30. 30.
    Uher P, Nyman U, Lindh M, et al. Long-term results of stenting for chronic iliac artery occlusion. J Endovasc Ther. 2002;9:67–75.PubMedGoogle Scholar
  31. 31.
    MacTaggart JN, Phillips NY, Lomneth CS, Pipinos II, Bowen R, Baxter BT, et al. Three-dimensional bending, torsion and axial compression of the femoropopliteal artery during limb flexion. J Biomech. 2014;47:2249–56.CrossRefGoogle Scholar
  32. 32.
    Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285–92.CrossRefGoogle Scholar
  33. 33.
    Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879–88.CrossRefGoogle Scholar
  34. 34.
    Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G, VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910–9.CrossRefGoogle Scholar
  35. 35.
    Evans C, Peter N, Gibson M, Torrie EPH, Galland RB, Magee TR. Five-year retrograde transpopliteal angioplasty results compared with antegrade angioplasty. Ann R Coll Surg Engl. 2010;92(4):347–52.CrossRefGoogle Scholar
  36. 36.
    Soga YIida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T. Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable stent. J Vasc Surg. 2013;58:1547–55.CrossRefGoogle Scholar
  37. 37.
    Hong SJ, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y. Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery. JACC Cardiovasc Interv. 2015;8:472–80.CrossRefGoogle Scholar
  38. 38.
    Goltz JP, Kleemann M. Complex recanalization techniques for complex femoro-popliteal lesions: how to optimize outcomes. J Cardiovasc Surg. 2015;56:31–41.Google Scholar
  39. 39.
    Spinosa DJ, Harthun NL, Bissonette EA, Cage D, Leung DA, Angle JF, Hagspiel KD, Kern JA, Crosby I, Wellons HA, Hartwell GD, Matsumoto AH. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol. 2005;16(1):37–44.CrossRefGoogle Scholar
  40. 40.
    Rundback JH, Herman KC, Patel A. Superficial femoral artery intervention: creating an algorithmic approach for the use of old and novel (endovascular) technologies. Curr Treat Options Cardiovasc Med. 2015;17(9):400–8.CrossRefGoogle Scholar
  41. 41.
    Das T, Mustapha J, Indes J, Vorhies R, Beasley R, Doshi N, et al. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv. 2014;83:115–22.CrossRefGoogle Scholar
  42. 42.
    Cioppa A, Stabile E, Popusoi G, Salemme L, Cota L, Pucciarelli A, et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med. 2012;13:219–23.CrossRefGoogle Scholar
  43. 43.
    Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg. 2011;54(4):1042–50.CrossRefGoogle Scholar
  44. 44.
    Brescia AA, Wickers BM, Correa JC, Smeds MR, Jacobs DL. Stenting of femoropopliteal lesions using interwoven nitinol stents. J Vasc Surg. 2015;51(6):1472–8.CrossRefGoogle Scholar
  45. 45.
    McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA, on behalf of the DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7:923–33.CrossRefGoogle Scholar
  46. 46.
    Bosiers M, Peeters P, Tessarek J, Deloose K, Strickler S, Zilver PTX Single-Arm Study Investigators. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg. 2013;54:115–22.Google Scholar
  47. 47.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther. 2014;21:359–68.CrossRefGoogle Scholar
  48. 48.
    Fischer M, Schwabe C, Schulte KL. Value of hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years experience. J Endovasc Ther. 2006;13:281–90.CrossRefGoogle Scholar
  49. 49.
    Saxon RR, Chervu A, Jones PA, Bajwa TK, Gable DR, Soukas PA, Begg RJ, Adams JG, Ansel GM, Schneider DB, Eichler CM, Rush MJ. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol. 2013;24:165–73.CrossRefGoogle Scholar
  50. 50.
    Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62:1320–7.CrossRefGoogle Scholar
  51. 51.
    Shackles C, Rundback JH, Herman K, David Y, Barkama R. Above and below knee femoropopliteal Viabahn. Catheter Cardiovasc Interv. 2015;85:859–67.CrossRefGoogle Scholar
  52. 52.
    Azéma L, Davaine JM, Guyomarch B, Chaillou P, Costargent A, Patra P, Gouëffic Y. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41(6):787–93.CrossRefGoogle Scholar
  53. 53.
    Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, Roffi M, Dorsaz PA, Schwarzwalder U, Burgelin K, Macharzina R, Zeller T. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58:792–8.CrossRefGoogle Scholar
  54. 54.
    Davies RSM, Adair W, Bolia A, Fishwick G, Sayers RD, McCarthy MJ. Endovascular treatment of the common femoral artery for limb ischemia. Vasc Endovasc Surg. 2013;47(8):639–44.CrossRefGoogle Scholar
  55. 55.
    Bonvini RF, Rastan A, Sixt S, Beschorner U, Noory E, Schwarz T, Roffi M, Dorsaz PA, Schwarzwalder U, Burgelin K, Macharzina R, Zeller T. Angioplasty and provisional stent treatment of common femoral artery lesions. J Vasc Interv Radiol. 2013;24:175–83.CrossRefGoogle Scholar
  56. 56.
    Thiney PO, Millon A, Boudjelit T, Schiava ND, Feugier P, Lermusiaux P. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg. 2015;29:960–7.CrossRefGoogle Scholar
  57. 57.
    Caligaro KD, Balraj P, Moudgill N, Rao A, Dougherty MJ, Eisenberg J. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament. J Vasc Surg. 2013;57:421–6.CrossRefGoogle Scholar
  58. 58.
    Lam RC, Shah S, Faries PL, McKinsey JF, Kent KC, Morrissey NJ. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg. 2007 Dec;46(6):1155–9.CrossRefGoogle Scholar
  59. 59.
    Spiliopoulos S, Theodosiadou V, Koukounas V, Katsanos K, Diamantopoulos A, Kitrou P, Ravazoula P, Siablis D, Karnabatidis D. Distal macro- and microembolization during subintimal recanalization of femoropopliteal chronic total occlusions. J Endovasc Ther. 2014;21(4):474–81.CrossRefGoogle Scholar
  60. 60.
    Shrikhande GV, Khan SZ, Hussain HG, Dayal R, McKinsey JF, Morrissey N. Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions. J Vasc Surg. 2011;53:347–52.CrossRefGoogle Scholar
  61. 61.
    Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26:355–60.PubMedGoogle Scholar
  62. 62.
    Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285–92.CrossRefGoogle Scholar
  63. 63.
    Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR, IN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495–502.CrossRefGoogle Scholar
  64. 64.
    Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014;7:10–9.CrossRefGoogle Scholar
  65. 65.
    Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T, Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61:2417–27.CrossRefGoogle Scholar
  66. 66.
    Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1–9.CrossRefGoogle Scholar
  67. 67.
    Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). J Am Coll Cardiol Intv. 2013;6:1295–302.CrossRefGoogle Scholar
  68. 68.
    Gray WA, Feiring A, Cioppi M, STROLL Study Investigators, et al. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes. J Vasc Interv Radiol. 2015;26(1):21–8.CrossRefGoogle Scholar
  69. 69.
    Nasser EPIC, Nasser F, Kambara A, Abath C, et al. Safety and efficacy of the EPIC Nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial. J Cardiovasc Surg. 2015;58(3):409–15. [Epub ahead of print].Google Scholar
  70. 70.
    Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K, SUPERB Trial Investigators. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial. Circ Cardiovasc Interv. 2015;8(5):pii: e000937. (epub ahead of print).CrossRefGoogle Scholar
  71. 71.
    Matsumura JS, Yamanouchi D, Goldstein JA, et al. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By using the Protégé EverfLex Nitinol Stent System II (DURABILITY II). J Vasc Surg. 2013;58:73–83.CrossRefGoogle Scholar
  72. 72.
    Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM, VIBRANT Investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013;58:386–95.CrossRefGoogle Scholar
  73. 73.
    Zeller T, Saratzis N, Scheinert D, Minar E, et al. Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent systemfor occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS TRIAL): acute and 30-dayresults. J Cardiovasc Surg. 2007;48(6):719–26.Google Scholar
  74. 74.
    Saxon RR, Chervu A, Jones PA, Bajwa TK, Gable DR, Soukas PA, Begg RJ, Adams JG, Ansel GM, Schneider DB, Eichler CM, Rush MJ. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn endoprosthesis with heparin bioactive surface in the treatment of superficial femoral artery obstructive disease) trial. J Vasc Interv Radiol. 2013;24:165–73.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Interventional Institute, Holy Name Medical CenterTeaneckUSA

Personalised recommendations